Genetics CME

Credits: 0.50 CME
Medical Learning Institute, Inc.
Acute Hepatic Porphyria: Disease Diagnosis and Revelations Regarding the Role of siRNA Therapy
Karl E. Anderson, MD
April 15, 2021
Credits: 1.00 CME
Medical Learning Institute, Inc.
New Milestones and Changing Standards of Care in EGFR-Mutated NSCLC: Expanding the Benefits of Genomic Testing and EGFR-Targeted Therapy to Early-Stage Lung Cancer
March 9, 2021
Credits: 1.00 CME
Medical Learning Institute, Inc.
Targeting DNA Repair Defects Through PARP Inhibition in Prostate Cancer: Rationale, Evidence, and Clinical Implications
Emmanuel S. Antonarakis, MD
July 22, 2020
Credits: 1.50 CME
Medical Learning Institute, Inc.
Assessing the Potential Role of Emerging Therapies in the Early Diagnosis and Optimal Management of Chronic Visceral Acid Sphingomyelinase Deficiency
Robin Lachmann, MD, PhD / Melissa Wasserstein, MD
June 3, 2020
Credits: 1.50 CME
Medical Learning Institute, Inc.
Targeting Pathogenic Mutations in the DNA Damage Response Pathway: Genetic Testing and Counseling in the Era of Precision Medicine and Next-Generation Sequencing
Mike Janicek, MD / Bradley J. Monk, MD, FACS, FACOG
May 27, 2020
Medical Learning Institute, Inc.
Novel Strategies and Emerging Evidence to Address Unmet Needs in Treating Patients With Long-Chain Fatty Acid Oxidation Disorders
Jerry Vockley, MD, PhD
January 31, 2020